Mechanisms of action of atypical antipsychotic drugs: a critical analysis

Arzneimittelforschung: Erstanwendung am Menschen in der Phase I

Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355

Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine

Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156

Psychopharmacology: The third generation of progress

O'Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,013

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., & Schwartz, J.-C. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,609

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia

Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

Kelly, P. H., Seviour, P. W., & Iversen, S. D. (1975) · Brain Research · doi:10.1016/0006-8993(75)90233-4 · Cited by 1,731

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine: Relation to Extrapyramidal Side Effects

Farde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,419

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

Meltzer, H. Y., Matsubara, S., & Lee, J. C. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20710-8 · Cited by 1,349

Risperidone in the treatment of schizophrenia

(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193

The current status of the dopamine hypothesis of schizophrenia

CARLSSON, A. (1988) · Neuropsychopharmacology · doi:10.1016/0893-133x(88)90012-7 · Cited by 958

Dopamine receptor pharmacology

Seeman, P., & Van Tol, H. H. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90323-9 · Cited by 956

Multiple dopamine D4 receptor variants in the human population

Tol, H. H. M. V., Wu, C. M., Guan, H.-C., Ohara, K., Bunzow, J. R., Civelli, O., Kennedy, J., Seeman, P., Niznik, H. B., & Jovanovic, V. (1992) · Nature · doi:10.1038/358149a0 · Cited by 955

Hypofrontality in Neuroleptic-Naive Patients and in Patients With Chronic Schizophrenia: Assessment With Xenon 133 Single-Photon Emission Computed Tomography and the Tower of London

Andreasen, N. C. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120031006 · Cited by 885

Dopamine receptors and the dopamine hypothesis of schizophrenia

Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880

A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients

CHOUINARD, G., JONES, B., REMINGTON, G., BLOOM, D., ADDINGTON, D., MacEWAN, G. W., LABELLE, A., BEAUCLAIR, L., & ARNOTT, W. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199302000-00004 · Cited by 876

Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area

Sesack, S. R., & Pickel, V. M. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903200202 · Cited by 820

PRE AND POSTSYNAPTIC RECEPTORS

Rees, D. (1976) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.10.1035 · Cited by 775

Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats

Kelly, P. H., & Iversen, S. D. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90352-6 · Cited by 715

Clozapine: A Novel Antipsychotic Agent

Oates, J. A., Wood, A. J. J., Baldessarini, R. J., & Frankenburg, F. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241107 · Cited by 687

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons

Chiodo, L., & Bunney, B. (1983) · The Journal of Neuroscience · doi:10.1523/jneurosci.03-08-01607.1983 · Cited by 680

Dopamine D4 receptors elevated in schizophrenia

Seeman, P., Guan, H.-C., & Van Tol, H. H. M. (1993) · Nature · doi:10.1038/365441a0 · Cited by 628

Parkinson's Disease and Movement Disorders

Kieburtz, K. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540220013003 · Cited by 616

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

Choudhary, M. S., Craigo, S., Sibley, D. R., Roth, B. L., Monsma, F. J., Shen, Y., Uluer, A., & Meltzer, H. Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/74zp-ze10 · Cited by 592

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

White, F. J., & Wang, R. Y. (1983) · Science · doi:10.1126/science.6136093 · Cited by 588

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1430 · Cited by 556

A hypervariable segment in the human dopamine receptor D4 (DRD4) gene

Lichter, J. B., Barr, C. L., Kennedy, J. L., Van Tol, H. H. M., Kidd, K. K., & Livak, K. J. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.6.767 · Cited by 524

Brain Morphology and Schizophrenia: A Magnetic Resonance Imaging Study of Limbic, Prefrontal Cortex, and Caudate Structures

Breier, A. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120009003 · Cited by 513

Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine

Robertson, G. S., & Fibiger, H. C. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90054-6 · Cited by 474

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

Janssen, P. A., Niemegeers, C. J., Awouters, F., Schellekens, K. H., Megens, A. A., & Meert, T. F. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24408-1 · Cited by 468

Burst Firing in Dopamine Neurons Induced by N -Methyl-D-aspartate: Role of Electrogenic Sodium Pump

Johnson, S. W., Seutin, V., & North, R. A. (1992) · Science · doi:10.1126/science.1329209 · Cited by 419

The Mechanism of Action of Novel Antipsychotic Drugs

Meltzer, H. Y. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.263 · Cited by 411

Norepinephrine-Dopamine Interactions and Behavior: A new hypothesis of stress-related interactions between brain norepinephrine and dopamine is proposed.

Antelman, S. M., & Caggiula, A. R. (1977) · Science · doi:10.1126/science.841304 · Cited by 409

Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis Study

Moghaddam, B., & Bunney, B. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01230.x · Cited by 402

Distribution of dopaminergic receptors in the primate cerebral cortex: Quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390

Lidow, M. S., Goldman-Rakic, P. S., Gallager, D. W., & Rakic, P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90003-7 · Cited by 394

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine

Hagger, C., Buckley, P., Kenny, J. T., Friedman, L., Ubogy, D., & Meltzer, H. Y. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90043-d · Cited by 393

Negative Symptoms and Hypofrontality in Chronic Schizophrenia

Wolkin, A. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120047007 · Cited by 393

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome

(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1744 · Cited by 382

Optimal Dose of Neuroleptic in Acute Schizophrenia: A Controlled Study of the Neuroleptic Threshold and Higher Haloperidol Dose

McEvoy, J. P. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320063009 · Cited by 381

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

MILLER, R. J., & HILEY, C. R. (1974) · Nature · doi:10.1038/248596a0 · Cited by 381

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

Christensen, A. V., Arnt, J., Hyttel, J., Larsen, J.-J., & Svendsen, O. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90607-6 · Cited by 373

Amelioration of negative symptoms in schizophrenia by glycine

(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1234 · Cited by 354

Clinical and Biologic Response to Clozapine in Patients With Schizophrenia: Crossover Comparison With Fluphenazine

Pickar, D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820050009001 · Cited by 354

Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors

Walters, J. R., & Roth, R. H. (1976) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00498834 · Cited by 350

IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS.

Janssen, P. A., Cj, N., & Schellekens, K. H. L. (1965) · PubMed · Cited by 348

3‐Methoxytyramine Is the Major Metabolite of Released Dopamine in the Rat Frontal Cortex: Reassessment of the Effects of Antipsychotics on the Dynamics of Dopamine Release and Metabolism in the Frontal Cortex, Nucleus Accumbens, and Striatum by a Simple Two Pool Model

Karoum, F., Chrapusta, S. J., & Egan, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030972.x · Cited by 347

Altered striatal function in a mutant mouse lacking D1A dopamine receptors.

Drago, J., Gerfen, C. R., Lachowicz, J. E., Steiner, H., Hollon, T. R., Love, P. E., Ooi, G. T., Grinberg, A., Lee, E. J., & Huang, S. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12564 · Cited by 343

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.10.1444 · Cited by 339

Effects of Six Months of Clozapine Treatment on the Quality of Life of Chronic Schizophrenic Patients

Meltzer, H. Y., Burnett, S., Bastani, B., & Ramirez, L. F. (1990) · Psychiatric Services · doi:10.1176/ps.41.8.892 · Cited by 338

Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine.

Nguyen, T. V., Kosofsky, B. E., Birnbaum, R., Cohen, B. M., & Hyman, S. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4270 · Cited by 331

Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice

Xu, M., Hu, X.-T., Cooper, D. C., Moratalla, R., Graybiel, A. M., White, F. J., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90026-4 · Cited by 331

Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat

Pijnenburg, A. J. J., Honig, W. M. M., & Van Rossum, J. M. (1975) · Psychopharmacologia · doi:10.1007/bf00421062 · Cited by 330

D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons

Robertson, G. S., Vincent, S. R., & Fibiger, H. C. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90096-k · Cited by 328

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

Farde, L., Wiesel, F. A., Nordstr�m, A. L., & Sedvall, G. (1989) · Psychopharmacology · doi:10.1007/bf00442555 · Cited by 325

Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex

Goldman-Rakic, P., Lidow, M., & Gallager, D. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02125.1990 · Cited by 312

Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors

Sanberg, P. R. (1980) · Nature · doi:10.1038/284472a0 · Cited by 308

Dopamine receptors and transporters in Parkinson's disease and schizophrenia

Seeman, P., & Niznik, H. B. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.10.2197154 · Cited by 300

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study

Claus, A., Bollen, J., Cuyper, H. D., Eneman, M., Malfroid, M., Peuskens, J., & Heylen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb01473.x · Cited by 295

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brain

Seeman, P., Guan, H. ‐., & Niznik, H. B. (1989) · Synapse · doi:10.1002/syn.890030113 · Cited by 293

Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system

Andén, N.-E., & Stock, G. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb10025.x · Cited by 291

The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia

Goldberg, T. E., Greenberg, R. D., Griffin, S. J., Gold, J. M., Kleinman, J. E., Pickar, D., Schulz, S. C., & Weinberger, D. R. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.1.43 · Cited by 289

Pharmacology and neurochemistry of buspirone.

Riblet, L. A., Taylor, D. P., Eison, M. S., & Stanton, H. C. (1982) · PubMed · Cited by 287

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance

Buchanan, R. W., Holstein, C., & Breier, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90082-5 · Cited by 281

The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent.

Moore, N. A., Tye, N. C., Axton, M. S., & Risius, F. C. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10792-1 · Cited by 278

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition

Ugedo, L., Grenhoff, J., & Svensson, T. H. (1989) · Psychopharmacology · doi:10.1007/bf00442004 · Cited by 267

Mechanisms of action of atypical antipsychotic drugs

Deutch, A. Y., Moghaddam, B., Innis, R. B., Krystal, J. H., Aghajanian, G. K., Bunney, B. S., & Charney, D. S. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90030-u · Cited by 253

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

Casey, D. E. (1989) · Psychopharmacology · doi:10.1007/bf00442559 · Cited by 251

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

Chakos, M., Lieberman, J., Alvir, J., Bilder, R. M., & Ashtari, M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90441-7 · Cited by 250

Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes.

Asghari, V, Schoots, O., van Kats, S., Ohara, K., Jovanovic, V, Guan, H. C., Bunzow, J. R., Petronis, A., & Van Tol, H. H. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09692-0 · Cited by 239

Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: Evidence for the involvement of both dopaminergic and GABAergic components

Pirot, S., Godbout, R., Mantz, J., Tassin, J.-P., Glowinski, J., & Thierry, A.-M. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90362-6 · Cited by 239

3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors

Hjorth, S., Carlsson, A., Wikström, H., Lindberg, P., Sanchez, D., Hacksell, U., Arvidsson, L.-E., Svensson, U., & Nilsson, J. L. G. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90448-3 · Cited by 229

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

Schotte, A., Janssen, P. F. M., Megens, A. A. H. P., & Leysen, J. E. (1993) · Brain Research · doi:10.1016/0006-8993(93)91535-z · Cited by 227

5-HT2 and D2 dopamine receptor occupancy in the living human brain: A PET study with risperidone

Nyberg, S., Farde, L., Eriksson, L., Halldin, C., & Eriksson, B. (1993) · Psychopharmacology · doi:10.1007/bf02251280 · Cited by 227

BindingDB Entry 4895: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

BindingDB (2011) · PubMed · doi:10.7270/q2154fjq · Cited by 224

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro

Richelson, E., & Nelson, A. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90478-3 · Cited by 223

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

Mita, T., Hanada, S., Nishino, N., Kuno, T., Nakai, H., Yamadori, T., Mizoi, Y., & Tanaka, C. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90332-x · Cited by 222

The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions

�gren, S., Hall, H., K�hler, C., Magnusson, O., & Sj�strand, S.-E. (1986) · Psychopharmacology · doi:10.1007/bf00179179 · Cited by 217

Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

Dewey, S., Smith, G., Logan, J., Alexoff, D., Ding, Y., King, P., Pappas, N., Brodie, J., & Ashby, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-01-00821.1995 · Cited by 215

Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo.

Prisco, S., Pagannone, S., & Esposito, E. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22843-9 · Cited by 214

Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.

Malmberg, A., Jackson, D. M., Eriksson, A., & Mohell, N. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13652-3 · Cited by 213

Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brain

Ögren, S. O., Hall, H., Köhler, C., Magnusson, O., Lindbom, L.-O., Ängeby, K., & Florvall, L. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90567-3 · Cited by 212

Risperidone: clinical safety and efficacy in schizophrenia.

Borison, R. L., Pathiraja, A., Diamond, B. I., & Meibach, R. C. (1992) · PubMed · Cited by 210

Iontophoretically administered drugs acting at the N‐methyl‐D‐aspartate receptor modulate burst firing in A9 dopamine neurons in the rat

Overton, P., & Clark, D. (1992) · Synapse · doi:10.1002/syn.890100208 · Cited by 208

Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine

Sayers, A. C., B�rki, H. R., Ruch, W., & Asper, H. (1975) · Psychopharmacologia · doi:10.1007/bf00421063 · Cited by 206

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations

Yamamoto, B., & Cooperman, M. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04159.1994 · Cited by 203

Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat

Lipska, B. K., Jaskiw, G. E., Chrapusta, S., Karoum, F., & Weinberger, D. R. (1992) · Brain Research · doi:10.1016/0006-8993(92)91184-g · Cited by 203

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

Pilowsky, L. S., Murray, R. M., Kerwin, R. W., Costa, D. C., Ell, P. J., & Verhoeff, N. P. L. G. (1992) · The Lancet · doi:10.1016/0140-6736(92)90467-h · Cited by 202

Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens

Chen, J., van Praag, H. M., & Gardner, E. L. (1991) · Brain Research · doi:10.1016/0006-8993(91)90050-6 · Cited by 200

Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat

Kalivas, P. W., & Duffy, P. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90271-0 · Cited by 199

Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.

Roth, B. L., Ciaranello, R. D., & Meltzer, H. Y. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11452-3 · Cited by 197

Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action

Ljungberg, T., & Ungerstedt, U. (1978) · Psychopharmacology · doi:10.1007/bf00432845 · Cited by 196

Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons

Chiodo, L., & Bunney, B. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-09-02539.1985 · Cited by 195

Survey on the pharmacodynamics of the new antipsychotic risperidone

Megens, A. A. H. P., Awouters, F. H. L., Schotte, A., Meert, T. F., Dugovic, C., Niemegeers, C. J. E., & Leysen, J. E. (1994) · Psychopharmacology · doi:10.1007/bf02245439 · Cited by 194

Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.

Seeman, P., Niznik, H. B., Guan, H. C., Booth, G., & Ulpian, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10156 · Cited by 191

Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat

Lipska, B. K., & Weinberger, D. R. (1993) · Developmental Brain Research · doi:10.1016/0165-3806(93)90026-7 · Cited by 189

Regional Cerebral Blood Flow in Monozygotic Twins Discordant and Concordant for Schizophrenia

Berman, K. F. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120015004 · Cited by 189

Brain catecholamines in schizophrenia — a good case for noradrenaline

Hornykiewicz, O. (1982) · Nature · doi:10.1038/299484a0 · Cited by 182

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia

Murray, A., Hyde, T., Knable, M., Herman, M., Bigelow, L., Carter, J., Weinberger, D., & Kleinman, J. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02186.1995 · Cited by 180

Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system

Bartholini, G. (1976) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1976.tb04648.x · Cited by 177

Prospective Study of Psychobiology in First-episode Schizophrenia at Hillside Hospital

Lieberman, J. A., Alvir, J. M. J., Woerner, M., Degreef, G., Bilder, R. M., Ashtari, M., Mayerhoff, D. I., Geisler, S. H., Loebel, A., Hinrichsen, G., et al. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.3.351 · Cited by 177

Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add-on double-blind, placebo-controlled study

Silver, H., & Nassar, A. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90279-9 · Cited by 176

Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations

Høyberg, O. J., Fensbo, C., Lingjærde, O., Sloth‐Nielsen, M., Salvesen, I., & Remvig, J. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03480.x · Cited by 176

Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.

Merchant, K. M., & Dorsa, D. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3447 · Cited by 174

A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.

Lidow, M. S., & Goldman-Rakic, P. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4353 · Cited by 173

Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs

Fitzgerald, L., Deutch, A., Gasic, G., Heinemann, S., & Nestler, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02453.1995 · Cited by 171

Serotonin-dopamine interactions in the nigrostriatal system

Waldmeier, P. C., & Delini-Stula, A. A. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90110-9 · Cited by 171

Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.

Stockmeier, C. A., DiCarlo, J. J., Zhang, Y., Thompson, P., & Meltzer, H. Y. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39339-0 · Cited by 170

Sexual behavior increases c-fos expression in the forebrain of the male rat

Robertson, G. S., Pfaus, J. G., Atkinson, L. J., Matsumura, H., Phillips, A. G., & Fibiger, H. C. (1991) · Brain Research · doi:10.1016/0006-8993(91)91477-i · Cited by 169

Ritanserin, a Selective 5-HT2/1CAntagonist, and Negative Symptoms in Schizophrenia: A Placebo-Controlled Double-Blind Trial

Duinkerke, S. J., Botter, P. A., Jansen, A. A. I., van Dongen, P. A. M., Haaften, A. J. V., Boom, A. J., Laarhoven, J. H. M. V., & Busard, H. L. S. M. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.4.451 · Cited by 156

Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja

MacGibbon, G. A., Lawlor, P. A., Bravo, R., & Dragunow, M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90207-0 · Cited by 152

Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

Karlsson, P., Farde, L., Härnryd, C., Sedvall, G., Smith, L. A., & Wiesel, F. ‐. (1995) · Psychopharmacology · doi:10.1007/bf02246068 · Cited by 149

Serotonergic involvement in haloperidol-induced catalepsy.

Neal‐Beliveau, B. S., Joyce, J. N., & Lucki, I. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38100-0 · Cited by 148

Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.

Živković, B., Guidotti, A., Revuelta, A., & Costa, E. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30226-0 · Cited by 147

Behavioral aspects of serotonin-dopamine interaction in the monkey

Korsgaard, S., Gerlach, J., & Christensson, E. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90135-9 · Cited by 146

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine

Costall, B., & Naylor, R. J. (1975) · Psychopharmacology · doi:10.1007/bf00437617 · Cited by 146

Receptor-Binding Profiles of Neuroleptics

Hyttel, J., Larsen, J. ‐., Christensen, A. V., & Arnt, J. (1985) · Psychopharmacology series · doi:10.1007/978-3-642-70140-5_2 · Cited by 145

Pharmacological profile of ritanserin: A very specific central serotonin S2‐antagonist

Awouters, F. H. L., Niemegeers, C. J. E., Megens, A. A. H. P., Meert, T. F., & Janssen, P. A. J. (1988) · Drug Development Research · doi:10.1002/ddr.430150107 · Cited by 139

Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications

Lahti, R. A., Evans, D. L., Stratman, N. C., & Figur, L. M. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90488-4 · Cited by 135

Animal Models in Psychiatry

Kinney, W. T. M. (1974) · Perspectives in biology and medicine · doi:10.1353/pbm.1974.0044 · Cited by 134

Haloperidol-induced morphological changes in striatum are associated with glutamate synapses

Meshul, C. K., Stallbaumer, R. K., Taylor, B. J., & Janowsky, A. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)91117-7 · Cited by 134

Effect of serotonin antagonism in schizophrenia: A pilot study with setoperone

Ceulemans, D. L. S., Gelders, Y. G., Hoppenbrouwers, M. J. A., Reyntjens, A. M., & Janssen, P. A. J. (1985) · Psychopharmacology · doi:10.1007/bf00428197 · Cited by 134

Blockade of Striatal 5‐Hydroxytryptmine2Receptors Reduces the Increase in Extracellullar Concentrations of Dopamine Produced by the Amphhetamine analogue 3,4‐Methylenedioxymethamphetamine

Schmidt, C. J., Sullivan, C. K., & Fedayal, G. M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62041382.x · Cited by 132

Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey

Selemon, L. D., & Goldman-Rakic, P. S. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902970304 · Cited by 131

8-hydroxy-2-(di-N-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis

Invernizzi, R. W., Cervo, L., & SAMANIN, R. (1988) · Neuropharmacology · doi:10.1016/0028-3908(88)90134-7 · Cited by 128

Risperidone for hallucinations in levodopa-treated Parkinson's disease patients

Meco, G., Alessandria, A., Bonifati, V., & Giustini, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92511-9 · Cited by 127

Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.

Richelson, E. (1984) · PubMed · Cited by 127

Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy

Balsara, J. J., Jadhav, J. H., & Chandorkar, A. G. (1979) · Psychopharmacology · doi:10.1007/bf00426037 · Cited by 126

In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: Implications for drug mechanisms of action

Cohen, B. M., & Lipinski, J. F. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90111-6 · Cited by 125

Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine

Kostowski, W., Gumulka, W. S., & Członkowski, A. (1972) · Brain Research · doi:10.1016/0006-8993(72)90208-9 · Cited by 125

Effects of clozapine on cerebral catecholaminergic neurone systems

Bartholini, G., Haefely, W. E., Jalfre, M., Keller, H. H., & Pletscher, A. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb06898.x · Cited by 124

Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs

Keller, H. H., Bartholini, G., & Pletscher, A. (1973) · European Journal of Pharmacology · doi:10.1016/0014-2999(73)90054-x · Cited by 123

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex

Nomikos, G. G., Iurlo, M., Andersson, J. L., Kimura, K., & Svensson, T. H. (1994) · Psychopharmacology · doi:10.1007/bf02244765 · Cited by 123

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

Hoffman, D. (1992) · Journal of Neural Transmission · doi:10.1007/bf01245347 · Cited by 122

Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain

Wilmot, C. A., & Szczepanik, A. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90833-0 · Cited by 119

Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity

Nöthen, M. M., Cichon, S., Hemmer, S., Hebebrand, J., Remschmidt, H., Lehmkuhl, G., Poustka, F., Schmidt, M., Catalano, M., Fimmers, R., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2207 · Cited by 119

On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs

Westerink, B. H. C., Lejeune, B., Korf, J., & van Praag, H. M. (1977) · European Journal of Pharmacology · doi:10.1016/0014-2999(77)90358-2 · Cited by 118

Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum

Merchant, K., Dobner, P., & Dorsa, D. M. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00652.1992 · Cited by 118

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats

Daly, D. A., & Moghaddam, B. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90483-2 · Cited by 117

Subjective response to neuroleptics and the quality of life: implications for treatment outcome

Awad, A. G., & Hogan, T. P. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb05828.x · Cited by 116

A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic system

Costall, B., & Naylor, R. J. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90348-4 · Cited by 115

The Effect of Clozapine on Plasma Norepinephrine: Relationship to Clinical Efficacy

Breier, A. F., Buchanan, R. W., Waltrip, R. W., Listwak, S. J., Holmes, C. S., & Goldstein, D. S. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.1 · Cited by 115

Seroquel: electrophysiological profile of a potential atypical antipsychotic

Goldstein, J. M., Litwin, L. C., Sutton, E. B., & Malick, J. B. (1993) · Psychopharmacology · doi:10.1007/bf02244924 · Cited by 114

Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients

Spina, E., Domenico, P. D., Ruello, C., et al. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400940-00007 · Cited by 112

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

O’Dell, S. J., LaHoste, G. J., Widmark, C., Shapiro, R. M., Potkin, S. G., & Marshall, J. F. (1990) · Synapse · doi:10.1002/syn.890060205 · Cited by 112

Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic system

Gallager, D. W., & Aghajanian, G. K. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90144-8 · Cited by 111

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

Smith, R. C., & Davis, J. M. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90170-3 · Cited by 111

Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs

Bowers, M. B., & Rozitis, A. (1974) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1974.tb09365.x · Cited by 111

Dreams, Hallucinogenic Drug States, and Schizophrenia: A Psychological and Biological Comparison

Fischman, L. G. (1983) · Schizophrenia Bulletin · doi:10.1093/schbul/9.1.73 · Cited by 108

Understanding the Mechanism of Action of Atypical Antipsychotic Drugs: A Review of Compounds in Use and Development

Lieberman, J. A. (1993) · British Journal of Psychiatry · doi:10.1192/s0007125000292544 · Cited by 108

Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons

Hand, T. H., Hu, X., & Wang, R. Y. (1987) · Brain Research · doi:10.1016/0006-8993(87)90207-1 · Cited by 107

PET Analysis Indicates Atypical Central Dopamine Receptor Occupancy in Clozapine-Treated Patients

Farde, L., & Nordström, A. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000296888 · Cited by 106

5-HT2 Antagonist Ritanserin in Neuroleptic-Induced Parkinsonism: A Double-Blind Comparison with Orphenadrine and Placebo

Bersani, G., Grispini, A., Marini, S., Pasini, A., Valducci, M., & Ciani, N. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199012000-00003 · Cited by 105

Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects

Seibyl, J. P., Krystal, J. H., Price, L. H., Woods, S. W., D'Amico, C., Heninger, G. R., & Charney, D. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90013-f · Cited by 104

High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET

Nordström, A., Farde, L., & Halldin, C. (1993) · Psychopharmacology · doi:10.1007/bf02251294 · Cited by 102

Opposing Roles for Dopamine D2 and D3 Receptors on Neurotensin mRNA Expression in Nucleus Accumbens

Díaz, J., Lévesque, D., Griffon, N., Lammers, C.-H., Martres, M., Sokoloff, P., & Schwartz, J. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00329.x · Cited by 102

The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia

Grace, A. A. (1992) · Springer eBooks · doi:10.1007/978-3-7091-9211-5_6 · Cited by 101

Clozapine: A 2‐year open trial in Parkinson's disease patients with psychosis

Factor, S. A., Brown, D. L., Molho, E., & Podskalny, G. D. (1994) · Neurology · doi:10.1212/wnl.44.3_part_1.544 · Cited by 101

Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine

Costall, B., & Naylor, R. J. (1976) · European Journal of Pharmacology · doi:10.1016/0014-2999(76)90311-3 · Cited by 101

Glycine Adjuvant Therapy to Conventional Neuroleptic Treatment in Schizophrenia

Rosse, R. B., Theut, S. K., Banay‐Schwartz, M., Leighton, M. P., Scarcella, E., Cohen, C. G., & Deutsch, S. I. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198910000-00006 · Cited by 101

Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei

Kilts, C. D., Anderson, C. M., Bissette, G., Ely, T. D., & Nemeroff, C. B. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90017-2 · Cited by 100

Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical Appraisal

Bürki, H. R., Eichenberger, E., Sayers, A., & White, T. G. (1975) · Pharmacopsychiatry · doi:10.1055/s-0028-1094449 · Cited by 99

Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo

Blaha, C. D., & Lane, R. F. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90633-1 · Cited by 98

m-Chlorophenylpiperazine Effects in Neuroleptic-Free Schizophrenic Patients

Krystal, J. H. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820200034004 · Cited by 98

Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia

Friedman, L., Knutson, L., Shurell, M., et al. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90053-o · Cited by 98

Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia

Hashimoto, T., Kitamura, N., Kajimoto, Y., Shirai, Y., Shirakawa, O., Mita, T., Nishino, N., & Tanaka, C. (1993) · Psychopharmacology · doi:10.1007/bf02245005 · Cited by 97

Double-blind Comparison of Risperidone and Haloperidol in Schizophrenic and Schizoaffective Psychoses

Češková, E., & Švestka, J. (1993) · Pharmacopsychiatry · doi:10.1055/s-2007-1014355 · Cited by 97

DOPAMINE AND SCHIZOPHRENIA

Crow, T. J., Johnstone, E. C., Deakin, J. F. W., & Longden, A. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91807-9 · Cited by 97

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

Reynolds, G. P., & Mason, S. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63041576.x · Cited by 96

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia

Wiesel, F., Nordström, A., Farde, L., & Eriksson, B. (1994) · Psychopharmacology · doi:10.1007/bf02245441 · Cited by 95

Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain

Fink‐Jensen, A., & Kristensen, P. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90220-8 · Cited by 93

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat

Rupniak, N. M. J., Hall, M. D., Mann, S., et al. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90577-5 · Cited by 93

Clonidine treatment of schizophrenia

Freedman, R., Kirch, D. G., Bell, J. A., Adler, L. E., Pecevich, M., Pachtman, E., & Denver, P. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb00819.x · Cited by 91

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

Cascella, N. G., Macciardi, F. M., Cavallini, M. C., & Smeraldi, E. (1994) · Journal of Neural Transmission · doi:10.1007/bf01276429 · Cited by 91

Prevalence and severity of akathisia in patients on clozapine

Cohen, B. M., Keck, P. E., Satlin, A., & Cole, J. O. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90329-k · Cited by 91

Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex

Matsubara, S., & Meltzer, H. Y. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90027-1 · Cited by 90

Serotonin2/1 C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibres

Leslie, R. A., Moorman, J. M., Coulson, A., & Smith, A. D. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90209-x · Cited by 89

Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: Acute and repeated treatment

Skarsfeldt, T. (1992) · Synapse · doi:10.1002/syn.890100105 · Cited by 86

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans — a PET study with [11C]SCH 23390 and [11C]raclopride

Farde, L. (1992) · Psychopharmacology · doi:10.1007/bf02244961 · Cited by 86

Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia

Drew, K. L., O'Connor, W. T., Kehr, J., et al. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90366-e · Cited by 86

ON THE RELEVANCE OF PREFERENTIAL INCREASES OF MESOLIMBIC VERSUS STRIATAL DOPAMINE TURNOVER FOR THE PREDICTION OF ANTIPSYCHOTIC ACTIVITY OF PSYCHOTROPIC DRUGS

Waldmeier, P. C., & Maître, L. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb12287.x · Cited by 85

Presynaptic dopamine release is enhanced by 5‐HT3 receptor activation in medial prefrontal cortex of freely moving rats

Chen, J., Paredes, W. M., van Praag, H. M., Lowinson, J. H., & Gardner, E. L. (1992) · Synapse · doi:10.1002/syn.890100308 · Cited by 84

Suppression of dyskinesias in advanced Parkinson's disease: II. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms

Bennett, J. P., Landow, E. R., & Schuh, L. A. (1993) · Neurology · doi:10.1212/wnl.43.8.1551 · Cited by 83

Depression as a lethal disease: prevention strategies.

Deutch, A. Y. (1994) · PubMed · Cited by 82

Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic‐induced dyskinesias

Egan, M. F., Hurd, Y. L., Hyde, T. M., et al. (1994) · Synapse · doi:10.1002/syn.890180303 · Cited by 82

Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)

Carlsson, M. L. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244978 · Cited by 81

Clozapine—A serotonin antagonist?

Fink, H., Morgenstern, R., & Oelssner, W. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90297-1 · Cited by 80

Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory turbercle of the rat

Wiesel, F., & Sedvall, G. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90123-5 · Cited by 80

The Effects of Haloperidol and Clozapine on Extracellular GABA Levels in the Prefrontal Cortex of the Rat: An in vivo Microdialysis Study

Bourdelais, A. J., & Deutch, A. Y. (1994) · Cerebral Cortex · doi:10.1093/cercor/4.1.69 · Cited by 80

Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: Antagonism by atypical antipsychotic drugs

Gellman, R. L., & Aghajanian, G. K. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90077-9 · Cited by 80

Clozapine response and plasma catecholamines and their metabolites

Green, A. I., Alam, M. Y., Sobieraj, J. T., Pappalardo, K. M., WATERNAUX, C. M., Salzman, C., Schatzberg, A. F., & Schildkraut, J. J. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90016-a · Cited by 78

Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors

Reynolds, G. P., Garrett, N. J., Rupniak, N. M. J., Jenner, P. G., & MARSDEN, C. D. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90517-4 · Cited by 76

An Animal Model for Coexisting Tardive Dyskinesia and Tardive Parkinsonism

Gunne, L. M., & Andrén, P. E. (1993) · Clinical Neuropharmacology · doi:10.1097/00002826-199302000-00012 · Cited by 76

Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis

Hernandez, L., & Hoebel, B. G. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90097-x · Cited by 74

Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment

Sebens, J. B., Koch, T., Horst, G. J. T., & Korf, J. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00692-z · Cited by 73

Treatment of drug-induced psychosis in Parkinson's disease with clozapine.

Greene, P., Côté, L., & Fahn, S. (1993) · PubMed · Cited by 73

Dopamine Uptake Sites and Dopamine Receptors in Parkinson’s Disease and Schizophrenia

Pearce, R. K. B., Seeman, P. M., Jellinger, K., & Tourtellotte, W. W. (2008) · European Neurology · doi:10.1159/000117168 · Cited by 72

Beta-adrenoceptor antagonists in neuropsychiatry: an update.

LADER, M. H. (1988) · PubMed · Cited by 72

The relative importance of dopamine and norepinephrine in mediating locomotor activity

Fishman, R. H., Feigenbaum, J. J., Yanai, J., & Klawans, H. L. (1983) · Progress in Neurobiology · doi:10.1016/0301-0082(83)90010-2 · Cited by 71

The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine

Karler, R., Calder, L. D., Thai, L. H., & Bedingfield, J. B. (1995) · Brain Research · doi:10.1016/0006-8993(94)01334-e · Cited by 71

Dopamine D2 receptors and dopamine metabolismRelationship between biochemical and behavioural effects of substituted benzamide drugs

MAGNUSSO, O., Fowler, C. J., Köhler, C., & Ögren, S. O. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90040-7 · Cited by 70

Does Fast Dissociation From the Dopamine D 2 Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis

Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140

The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics

Heidbreder, C. A., & Groenewegen, H. J. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.09.003 · Cited by 882

Schizophrenia, dopamine and the striatum: From biology to symptoms

McCutcheon, R. A., Abi-Dargham, A., & Howes, O. D. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.12.004 · Cited by 763

The reinterpretation of dreams: An evolutionary hypothesis of the function of dreaming

Revonsuo, A. (2000) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004015 · Cited by 676

The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1313-x · Cited by 391